Enhanced anti-tumour effect of cisplatin with low-voltage electrochemotherapy in hamster oral fibrosarcoma

Journal of International Medical Research

Volumn 33, Issue 5, 2005, Pages 507-512

  Fujimoto, T ^a   Maeda, H ^a   Kubo, K ^a   Sugita, Y ^a   Nakashima, T ^a   Sato, E ^a   Tanaka, Y ^a   Madachi, M ^a   Aiba, M ^a   Kameyama, Y ^a  

^a AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

Anti tumour; Cisplatin; Electrochemotherapy; Fibrosarcoma; Hamster; Low voltage; Oral lesion

Indexed keywords

CISPLATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; ELECTROCHEMOTHERAPY; FIBROSARCOMA; MALE; MOUTH TUMOR; MULTIMODALITY CANCER THERAPY; NONHUMAN; SYRIAN HAMSTER; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 25844490850     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000503300505     Document Type: Article

References (16)

1. Mir LM, Orlowski S: Mechanisms of electrochemotherapy. Adv Drug Deliv Rev 1999; 35: 107-118.
2. Sersa G: Electrochemotherapy: animal work review. In: Electrochemotherapy, Electrogenetherapy and Transdermal Drug Delivery, Electrically Mediated Delivery of Molecules to Cells (Jaroszeski MJ, Heller R, Gilbert R, eds). Totowa, New Jersey: Humana Press, 2000; pp119-1136.
3. Belehradek J, Jr, Orlowski S, Ramirez LH, Pron G, Poddevin B, Mir LM: Electropermeabilization of cells in tissues assessed by the qualitative and quantitative electroloading of bleomycin. Biochim Biophys Acta 1994; 1190: 155-163.
4. Cemazar M, Miklavcic D, Scancar J, Dolzan V, Golouh R, Sersa G: Increased platinum accumulation in SA-1 tumour cells after in vivo electrochemotherapy with cisplatin. Br J Cancer 1999; 79: 1386-1391.
5. Mir LM, Glass LF, Sersa G, Teissie J, Domenge C, Miklavcic D, et al: Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer 1998; 77: 2336-2342.
6. Sersa G, Stabuc B, Cemazar M, Miklavcic D, Rudolf Z: Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients. Clin Cancer Res 2000; 6: 863-867.
7. Haskell CM: Drugs used in cancer chemotherapy. In: Cancer Treatment (Haskell CM, ed). Philadelphia: WB Saunders, 1990, pp55-57.
8. Horiuchi A, Nikaido T, Mitsushita J, Toki T, Konishi I, Fujii S: Enhancement of antitumor effect of bleomycin by low-voltage in vivo electroporation: a study of human uterine leiomyosarcomas in nude mice. Int J Cancer 2000; 88: 640-644.
9. Miyazaki S, Gunji Y, Matsubara H, Shimada H, Uesato M, Suzuki T, et al: Possible involvement of antitumor immunity in the eradication of colon 26 induced by low-voltage electrochemotherapy with bleomycin. Surg Today 2003; 33: 39-44.
10. Isobe K, Shimizu T, Nikaido T, Takaoka K: Low-voltage electrochemotherapy with low-dose methotrexate enhances survival in mice with osteosarcoma. Clin Orthop Relat Res 2004; 426: 226-231.
11. Heller R, Jaroszeski MJ, Reintgen DS, Puleo CA, DeConti RC, Gilbert RA, et al: Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer 1998; 83: 148-157.
12. Rodriguez-Cuevas S, Barroso-Bravo S, Almanza-Estrada J, Cristobal-Martinez L, Gonzalez-Rodriguez E: Electrochemotherapy in primary and metastatic skin tumors: phase II trial using intralesional bleomycin. Arch Med Res 2001; 32: 273-276.
13. Cemazar M, Miklavcic D, Mir LM, Belehradek J, Jr, Bonnay M, Fourcault D, et al: Electrochemotherapy of tumours resistant to cisplatin: a study in a murine tumour model. Eur J Cancer 2001; 37: 1166-1172.
14. Sersa G, Krzic M, Sentjurc M, Ivanusa T, Beravs K, Kotnik V, et al: Reduced blood flow and oxygenation in SA-1 tumours after electrochemotherapy with cisplatin. Br J Cancer 2002; 87: 1047-1054.
15. Sersa G, Stabuc B, Cemazar M, Miklavcic D, Rudolf Z: Electrochemotherapy with cisplatin: the systemic antitumour effectiveness of cisplatin can be potentiated locally by the application of electric pulses in the treatment of malignant melanoma skin metastases. Melanoma Res 2000; 10: 381-385.
16. Meyn RE, Stephens LC, Hunter NR, Milas L: Kinetics of cisplatin-induced apoptosis in murine mammary and ovarian adenocarcinomas. Int J Cancer 1995; 60: 725-729.